{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:45:07Z","timestamp":1787003107716,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Administration of Traditional Chinese Medicine Key Discipline Construction Project of High-Level TCM","award":["ZYYZDXK-2023005"],"award-info":[{"award-number":["ZYYZDXK-2023005"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304831"],"award-info":[{"award-number":["82304831"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Science Fund for Excellent Young Scholars","award":["242300421090"],"award-info":[{"award-number":["242300421090"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023TQ0109, GZB20230196"],"award-info":[{"award-number":["2023TQ0109, GZB20230196"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Associates Fund of Henan Province science and technology research and development program","award":["232301420077"],"award-info":[{"award-number":["232301420077"]}]},{"name":"Young Talent Support Program of Henan Association for Science and Technology","award":["2025HYTP092"],"award-info":[{"award-number":["2025HYTP092"]}]},{"name":"Central Plains Science and Technology Innovation Young Top Talent Project","award":["NA (2024)"],"award-info":[{"award-number":["NA (2024)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Sci Food"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global health burden with limited therapeutic options.\n                    <jats:italic>Cinnamomum cassia<\/jats:italic>\n                    , a medicinal-food homologous plant, contains principal bioactive cinnamaldehyde (CA), whose anti-MASLD mechanisms require clarification. \u200cThis study employed both a high-fat diet (HFD)-induced MASLD model and a free fatty acid (FFA)-stimulated cell model. CA administration attenuated intracellular lipid accumulation in vitro and ameliorated both hepatic steatosis and systemic hyperlipidemia in vivo, while inhibiting hepatic lipid peroxidation. Mechanistically, integrated RNA-seq, network pharmacology, siRNA, immunofluorescence, and transmission electron microscopy analyses identified the SIRT1\/FOXO1\u2013autophagy axis as CA\u2019s key regulatory pathway. Gut microbiome profiling revealed CA\u2019s capacity to ameliorate HFD-induced dysbiosis, particularly enriching\n                    <jats:italic>Lachnospiraceae_NK4A136<\/jats:italic>\n                    . Fecal microbiota transplantation (FMT) and Spearman correlations link serum lipids and hepatic injury factors to gut microbiota, indicating partially microbiota-mediated metabolic modulation by CA. Collectively, CA ameliorates MASLD through coordinated autophagy enhancement and microbial homeostasis restoration, holding promise as a functional food ingredient for \u200cmetabolic liver disease prevention.\n                  <\/jats:p>","DOI":"10.1038\/s41538-026-00815-6","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:28:14Z","timestamp":1775723294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cinnamaldehyde mitigates MASLD through SIRT1\/FOXO1-induced autophagy and synergistic gut microbiota modulation"],"prefix":"10.1038","volume":"10","author":[{"given":"Xiaoran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanyou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"815_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000112","volume":"7","author":"K Kantartzis","year":"2023","unstructured":"Kantartzis, K. et al. Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories. Hepatol. Commun. 7, e0112 (2023).","journal-title":"Hepatol. Commun."},{"key":"815_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/20420188221145549","volume":"14","author":"RM Pipitone","year":"2023","unstructured":"Pipitone, R. M. et al. MAFLD: a multisystem disease. Ther. Adv. Endocrinol. Metab. 14, 20420188221145549 (2023).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"815_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren, J. et al. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol. Metab. 50, 101238 (2021).","journal-title":"Mol. Metab."},{"key":"815_CR4","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R. et al. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 184, 2537\u20132564 (2021).","journal-title":"Cell"},{"key":"815_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam, S. J. Resmetirom: first approval. Drugs 84, 729\u2013735 (2024).","journal-title":"Drugs"},{"key":"815_CR6","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1021\/acs.jafc.2c00744","volume":"70","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. Protective effect and mechanism of plant-based monoterpenoids in non-alcoholic fatty liver diseases. J. Agric. Food Chem. 70, 4839\u20134859 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"815_CR7","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1021\/acs.jafc.8b05032","volume":"67","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. Preventive efficiency of green tea and its components on nonalcoholic fatty liver disease. J. Agric. Food Chem. 67, 5306\u20135317 (2019).","journal-title":"J. Agric. Food Chem."},{"key":"815_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1087260","volume":"13","author":"L Rong","year":"2022","unstructured":"Rong, L. et al. Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front. Endocrinol. 13, 1087260 (2022).","journal-title":"Front. Endocrinol."},{"key":"815_CR9","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1080\/10408398.2021.1977236","volume":"63","author":"B Muhoza","year":"2023","unstructured":"Muhoza, B. et al. Encapsulation of cinnamaldehyde: an insight on delivery systems and food applications. Crit. Rev. Food Sci. Nutr. 63, 2521\u20132543 (2023).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"815_CR10","first-page":"140","volume":"32","author":"J Peng","year":"2024","unstructured":"Peng, J. et al. The role and mechanism of cinnamaldehyde in cancer. J. Food Drug Anal. 32, 140\u2013154 (2024).","journal-title":"J. Food Drug Anal."},{"key":"815_CR11","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/polym15061517","volume":"15","author":"G Zhang","year":"2023","unstructured":"Zhang, G. et al. Cinnamaldehyde-contained polymers and their biomedical applications. Polymers. (Basel) 15, 1517 (2023).","journal-title":"Polymers. (Basel)"},{"key":"815_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2019.108321","volume":"77","author":"JGO Neto","year":"2020","unstructured":"Neto, J. G. O. et al. Treatment with cinnamaldehyde reduces the visceral adiposity and regulates lipid metabolism, autophagy and endoplasmic reticulum stress in the liver of a rat model of early obesity. J. Nutr. Biochem. 77, 108321 (2020).","journal-title":"J. Nutr. Biochem."},{"key":"815_CR13","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3390\/molecules26082309","volume":"26","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Protective effects of cinnamaldehyde on the inflammatory response, oxidative stress, and apoptosis in liver of Salmonella typhimurium-challenged mice. Molecules 26, 2309 (2021).","journal-title":"Molecules"},{"key":"815_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.cell.2019.05.026","volume":"177","author":"L Galluzzi","year":"2019","unstructured":"Galluzzi, L. et al. Autophagy-independent functions of the autophagy machinery. Cell 177, 1682\u20131699 (2019).","journal-title":"Cell"},{"key":"815_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1042\/EBC20170035","volume":"61","author":"T Lamark","year":"2017","unstructured":"Lamark, T. et al. Regulation of selective autophagy: the p62\/SQSTM1 paradigm. Essays Biochem. 61, 609\u2013624 (2017).","journal-title":"Essays Biochem."},{"key":"815_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3389\/fphys.2020.00850","volume":"11","author":"S Carotti","year":"2020","unstructured":"Carotti, S. et al. Lipophagy impairment is associated with disease progression in NAFLD. Front. Physiol. 11, 850 (2020).","journal-title":"Front. Physiol."},{"key":"815_CR17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.bbalip.2017.06.008","volume":"1862","author":"RJ Schulze","year":"2017","unstructured":"Schulze, R. J. et al. Breaking fat: the regulation and mechanisms of lipophagy. Biochim. Biophys. Acta 1862, 1178\u20131187 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"815_CR18","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3390\/ijms14023834","volume":"14","author":"A Salminen","year":"2013","unstructured":"Salminen, A. et al. Crosstalk between oxidative stress and SIRT1: impact on the aging process. Int. J. Mol. Sci. 14, 3834\u20133859 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"815_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ncb2069","volume":"12","author":"Y Zhao","year":"2010","unstructured":"Zhao, Y. et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol. 12, 665\u2013675 (2010).","journal-title":"Nat. Cell Biol."},{"key":"815_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2478\/v10039-012-0039-1","volume":"57","author":"M W\u0105troba","year":"2012","unstructured":"W\u0105troba, M. et al. Current overview of functions of FoxO proteins, with special regards to cellular homeostasis, cell response to stress, as well as inflammation and aging. Adv. Med. Sci. 57, 183\u2013195 (2012).","journal-title":"Adv. Med. Sci."},{"key":"815_CR21","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.3748\/wjg.v30.i29.3456","volume":"30","author":"W Zhu","year":"2024","unstructured":"Zhu, W. Effective roles of exercise and diet adherence in non-alcoholic fatty liver disease. World J. Gastroenterol. 30, 3456\u20133460 (2024).","journal-title":"World J. Gastroenterol."},{"key":"815_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic. Biol. Med. 152, 116\u2013141 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"815_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jdiacomp.2015.08.022","volume":"30","author":"Y Cao","year":"2016","unstructured":"Cao, Y. et al. SIRT1 and insulin resistance. J. Diab. Complicat. 30, 178\u2013183 (2016).","journal-title":"J. Diab. Complicat."},{"key":"815_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/15548627.2020.1860541","volume":"17","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. SIRT1\u2014a new mammalian substrate of nuclear autophagy. Autophagy 17, 593\u2013595 (2021).","journal-title":"Autophagy"},{"key":"815_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.lfs.2017.11.030","volume":"193","author":"YQ Xing","year":"2018","unstructured":"Xing, Y. Q. et al. The regulation of FOXO1 and its role in disease progression. Life Sci. 193, 124\u2013131 (2018).","journal-title":"Life Sci."},{"key":"815_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.apsb.2021.07.021","volume":"12","author":"K Byrnes","year":"2022","unstructured":"Byrnes, K. et al. Therapeutic regulation of autophagy in hepatic metabolism. Acta Pharm. Sin. B 12, 33\u201349 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"815_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101635","volume":"36","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol. 36, 101635 (2020).","journal-title":"Redox Biol."},{"key":"815_CR28","doi-asserted-by":"publisher","first-page":"e002171","DOI":"10.1136\/openhrt-2022-002171","volume":"9","author":"JJ DiNicolantonio","year":"2022","unstructured":"DiNicolantonio, J. J. et al. Nutraceutical activation of Sirt1: a review. Open Heart 9, e002171 (2022).","journal-title":"Open Heart"},{"key":"815_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4062\/biomolther.2017.119","volume":"25","author":"CJ Lim","year":"2017","unstructured":"Lim, C. J. et al. Aquatide activation of SIRT1 reduces cellular senescence through a SIRT1\u2013FOXO1\u2013autophagy axis. Biomol. Ther. 25, 511\u2013518 (2017).","journal-title":"Biomol. Ther."},{"key":"815_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.100973","volume":"82","author":"H Qian","year":"2021","unstructured":"Qian, H. et al. Autophagy in liver diseases: a review. Mol. Asp. Med. 82, 100973 (2021).","journal-title":"Mol. Asp. Med."},{"key":"815_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/metabo13010101","volume":"13","author":"L An","year":"2023","unstructured":"An, L. et al. Metabolic role of autophagy in the pathogenesis and development of NAFLD. Metabolites 13, 101 (2023).","journal-title":"Metabolites"},{"key":"815_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38165-6","volume":"14","author":"J Zeng","year":"2023","unstructured":"Zeng, J. et al. Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease. Nat. Commun. 14, 2573 (2023).","journal-title":"Nat. Commun."},{"key":"815_CR33","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","volume":"20","author":"S Mili\u0107","year":"2014","unstructured":"Mili\u0107, S. et al. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J. Gastroenterol. 20, 9330\u20139337 (2014).","journal-title":"World J. Gastroenterol."},{"key":"815_CR34","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","volume":"63","author":"F Ameer","year":"2014","unstructured":"Ameer, F. et al. De novo lipogenesis in health and disease. Metabolism 63, 895\u2013902 (2014).","journal-title":"Metabolism"},{"key":"815_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1389557516666160121120744","volume":"17","author":"BJ Chen","year":"2017","unstructured":"Chen, B. J. et al. Cinnamaldehyde analogues as potential therapeutic agents. Mini Rev. Med. Chem. 17, 33\u201343 (2017).","journal-title":"Mini Rev. Med. Chem."},{"key":"815_CR36","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.3390\/ijms22084156","volume":"22","author":"Y Sakurai","year":"2021","unstructured":"Sakurai, Y. et al. Role of insulin resistance in MAFLD. Int. J. Mol. Sci. 22, 4156 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"815_CR37","doi-asserted-by":"publisher","first-page":"e64953","DOI":"10.1371\/journal.pone.0064953","volume":"8","author":"BH Shin","year":"2013","unstructured":"Shin, B. H. et al. Pharmacological activation of Sirt1 ameliorates polyglutamine-induced toxicity through the regulation of autophagy. PLoS ONE 8, e64953 (2013).","journal-title":"PLoS ONE"},{"key":"815_CR38","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.3390\/ijms22147475","volume":"22","author":"T Hamano","year":"2021","unstructured":"Hamano, T. et al. Autophagy and tau protein. Int J. Mol. Sci. 22, 7475 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"815_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11892-009-0034-5","volume":"9","author":"DN Gross","year":"2009","unstructured":"Gross, D. N. et al. The role of FOXO in the regulation of metabolism. Curr. Diabetes Rep. 9, 208\u2013214 (2009).","journal-title":"Curr. Diabetes Rep."},{"key":"815_CR40","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","volume":"76","author":"E Scorletti","year":"2022","unstructured":"Scorletti, E. et al. A new perspective on NAFLD: focusing on lipid droplets. J. Hepatol. 76, 934\u2013945 (2022).","journal-title":"J. Hepatol."},{"key":"815_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-981-10-8684-7_10","volume":"1061","author":"WKK Wu","year":"2018","unstructured":"Wu, W. K. K. et al. Autophagy, NAFLD and NAFLD-related HCC. Adv. Exp. Med. Biol. 1061, 127\u2013138 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"815_CR42","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1210\/en.2017-00870","volume":"159","author":"AV Ling","year":"2018","unstructured":"Ling, A. V. et al. FoxO1 is required for most of the metabolic and hormonal perturbations produced by hepatic insulin receptor deletion in male mice. Endocrinology 159, 1253\u20131263 (2018).","journal-title":"Endocrinology"},{"key":"815_CR43","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7150\/ijbs.78654","volume":"19","author":"C Lu","year":"2023","unstructured":"Lu, C. et al. Novel role of the SIRT1 in endocrine and metabolic diseases. Int. J. Biol. Sci. 19, 484\u2013501 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"815_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107155","volume":"203","author":"C Tian","year":"2024","unstructured":"Tian, C. et al. SIRT1: harnessing multiple pathways to hinder NAFLD. Pharm. Res. 203, 107155 (2024).","journal-title":"Pharm. Res."},{"key":"815_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","volume":"49","author":"E Cobbina","year":"2017","unstructured":"Cobbina, E. et al. Non-alcoholic fatty liver disease (NAFLD)\u2014pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab. Rev. 49, 197\u2013211 (2017).","journal-title":"Drug Metab. Rev."},{"key":"815_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora, E. E. et al. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat. Rev. Endocrinol. 15, 261\u2013273 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"815_CR47","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s11154-023-09843-z","volume":"24","author":"M Jayachandran","year":"2023","unstructured":"Jayachandran, M. et al. Non-alcoholic fatty liver disease and gut microbial dysbiosis\u2014underlying mechanisms and gut microbiota mediated treatment strategies. Rev. Endocr. Metab. Disord. 24, 1189\u20131204 (2023).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"815_CR48","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1111\/jgh.15903","volume":"37","author":"JJ Jee","year":"2022","unstructured":"Jee, J. J. et al. Gut microbial community differentially characterizes patients with nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 37, 1822\u20131832 (2022).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"815_CR49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","volume":"17","author":"M Schirmer","year":"2019","unstructured":"Schirmer, M. et al. Microbial genes and pathways in inflammatory bowel disease. Nat. Rev. Microbiol. 17, 497\u2013511 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"815_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.132057","volume":"459","author":"C Yan","year":"2023","unstructured":"Yan, C. et al. Adverse effect of oxidized cholesterol exposure on colitis is mediated by modulation of gut microbiota. J. Hazard. Mater. 459, 132057 (2023).","journal-title":"J. Hazard. Mater."},{"key":"815_CR51","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 50, W159\u2013W164 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Science of Food"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00815-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:05:10Z","timestamp":1781089510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00815-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1038\/s41538-026-00815-6","relation":{},"ISSN":["2396-8370"],"issn-type":[{"value":"2396-8370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}